BioCryst Pharmaceuticals, Inc. (BCRX)

9.70 -0.11 (-1.12%) USD  |  NASDAQ  |  Mar 20, 16:00
9.90 +0.20 (+2.06%) Pre-Market: 09:05
More

BioCryst Pharmaceuticals Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade